failed_experiment.db
← Back to browse

Medicine› Endocrinology, Diabetes and Metabolism› Thyroid Disorders and Treatments

Graves' disease — Vitamin D supplementation after anti-thyroid drug withdrawal

Submitted 2026-10-22

Field: Medicine › Endocrinology, Diabetes and MetabolismType: No effect foundArea: graves' diseaseTarget: Vitamin D supplementation after anti-thyroid drug withdrawalStage: full study

Hypothesis

Correcting vitamin D deficiency with daily supplements would lower the rate at which Graves' disease comes back after anti-thyroid drugs are stopped.

What failed

Of 210 vitamin D-deficient patients followed for at least a year after stopping anti-thyroid drugs, the 60 who took supplements relapsed at a rate not significantly different from the 150 who did not (38% vs 49%, P = 0.086), although relapse came somewhat later in the supplemented group.

Broken assumption

Raising vitamin D levels is enough to measurably prevent Graves' relapse.

Why

The authors read the difference as a borderline protective trend; the groups were self-selected rather than randomised, and vitamin D level at drug withdrawal still tracked with relapse in multivariate analysis.

From the published paper: Cho et al. Scientific Reports, 2020. ↗CC BY

Research ideas from this failure

Unvetted lead — read the papers

New hypotheses this failure suggests, each with a crucial experiment, a rival explanation of the original result, and the papers it rests on. Written by AI from paper titles and abstracts found on OpenAlex (and Europe PMC, for life and health sciences).

Related failures

Nothing else logged looks close to this one yet.

Links in published research

Where this experiment's genes are known to matter outside its own research area, and the papers behind those links. Sources: Open Targets Platform and Europe PMC.